Case reports suggest that the course of syphilis is altered in patients infected with human immunodeficiency virus (HIV). To investigate this issue, a model of syphilis in rhesus macaques with and without simian immunodeficiencyvirus (SIV) was developed.After intradermal inoculation with Treponema pallidum, 2 SIV-infected monkeys had persistent ulcerative primary lesions and 1 developed secondary syphilis. Two SIV-uninfected controls developed transient nonulcerative primary lesions. Only the controls showed consistent VDRL antibody responses. In contrast, reciprocal antibody titers to T. pallidum detected by microhemagglutination were higher in SIV-infected animals (~20,480) than controls (~1280). All 4 animals developed a full range of T. pallidum antigen-specific antibodies shown by immunoblot and had similar peak lymphocyte proliferative responses to T. pallidum antigens. These results support the contention that retrovirus-induced immunodeficiency delays clearance of T. pallidum from sites of infection and may impair the humoral immune response to syphilis.
In the past 10 years, a number of case reports have suggested that the clinical course of syphilis and the response to antibiotic therapy may be altered in patients who are also infected with human immunodeficiency virus (HIV). Most of these reports describe development of syphilitic meningitis or cerebral vasculitis and ocular syphilis, previously uncommon manifestations of syphilis, in patients coinfected with HIV and syphilis [I, 2] . Several of these patients had prior treatment with benzathine penicillin G for early syphilis. Less commonly, unusual or more severe cutaneous manifestations of secondary syphilis and delayed healing of skin lesions after therapy have been described [3] [4] [5] . A few HIVinfected persons with biopsy-proven secondary syphilis and nonreactive serum nontreponemal serologic tests have been reported [3, 6, 7] .
Because these observations are based on case reports, however, and because similar atypical cases occurred before the advent of HI V, the true frequency and relative importance of these unusual manifestations of syphilis and their relationship to HIV infection are unknown. Prospective studies in humans will help clarify these issues but will suffer from inability to define the precise time of Treponema pallidum infection, noncompliance, incidental antibiotic therapy, inability to study untreated controls, and other difficulties. An animal model of syphilis in conjunction with retrovirus-induced immunodeficiency might help elucidate the natural course ofsyphilis in Hlv-infected patients. The immunodeficiency and illness caused by simian immunodeficiency virus (SIV) in macaques are similar to those produced by HIV in humans [8] . Therefore, we conducted a pilot study to investigate the course of experimental primary syphilis in rhesus macaques with and without SIV infection and here report the results of the first 6 months of observation.
Materials and Methods
Animals. Juvenile (2-3 years old), male, colony-born Macaca mulatta with nonreactive VDRL tests and microhemagglutination assays for T. pallidum (MHA-TP) were housed individually at 25°C and were fed antibiotic-free food and water.
Adult male New Zealand White rabbits without evidence of Treponema paraluiscuniculi infection (nonreactive VDRL and fluorescent treponemal antibody absorption [FfA-ABSj tests)
were housed individually at 19-20°C and were fed antibioticfree food and water.
Source of organisms. T. pallidum subspecies pallidum, Nichols strain, was propagated in rabbits as previously described [9] . After sacrifice, infected testes were sliced longitudinally and extracted by gentle rotation in 50% normal rabbit serum in 0.9% saline. The extraction medium was centrifuged at 280 g for 10 min, and motile organisms in the supernatant were counted by darkfield microscopy and adjusted to 5.0 X 10 7organisms/m!.
Experimental design and procedures. Four macaques were inoculated intradermally with 10 7 live T. pallidum (in 0.2 ml) at each offour sites on the back, and the back was kept clipped free of hair. Two of the 4 animals had been intravenously inoculated with 10 3 TCID of wild-type SIVmne [10] 3 months before T. paflidum infection. This timing was chosen to model syphilis infection in an immunocompromised individual without AIDS; experience at the University of Washington Regional Primate Center suggests that rhesus macaques develop opportunistic infection 6-18 months after inoculation with this strain.
Animals were sedated with ketamine (10 mg/kg) and examined for clinical manifestations of syphilis three times weekly for the first 12 weeks, twice weekly for weeks [13] [14] [15] [16] , and weekly for weeks [17] [18] [19] [20] [21] [22] [23] [24] . Touch preparations were made from skin lesion exudate, and biopsies of skin lesions were obtained on days 14 and 95. Blood samples were collected by venipuncture before (baseline) and every 2 weeks after syphilis infection for VDRL test, MHA-TP, immunoblot, and lymphocyte culture. Proportions of peripheral blood T lymphocyte subsets were determined at 0, 4, 6, 8, 12, 16, and 20 weeks.
Cerebrospinal fluid (CSF) was collected by lumbar puncture with a 22-gauge 3.8-cm spinal needle before (baseline) and every 2 weeks (except for week 6) after syphilis infection. CSF samples containing~2000 red blood cells/ul were discarded because this amount ofCSF blood contamination has produced false-positive CSF FTA-ABS tests (but not CSF VDRL tests) in humans with secondary syphilis [II] . CSF white blood cell counts were determined at each time point. CSF VDRL test, CSF MHA-TP, and CSF and serum determinations of total IgG and albumin were done 4, 8, 12, 16, 20 , and 24 weeks after infection. MHA-TP index (CSF MHA-TP titer X serum IgG/ serum MHA-TP titer X CSF IgG) and albumin ratios were calculated to determine intrathecal antitreponemal antibody synthesis and blood-brain barrier integrity, respectively [12] .
Antibody responses. The serum and CSF VDRL slide flocculation tests and serum MHA-TP were done by standard methods [13] . CSF MHA-TP was done as for serum except that CSF was not heated and was diluted I;2.5 in absorbing diluent [14] . Serum VDRL and FTA-ABS tests for recipient rabbits were done as previously described [15] ; known reactive and nonreactive rabbit sera were used as controls. VDRL reagents were obtained from Difco Laboratories (Detroit). FTA-ABS antigen and sorbent were obtained from SciMedx (Denville, NJ). Fluorescein-labeled goat anti-rabbit IgG (Zymed, South San Francisco) for the FT A-ABS test was used at a final dilution of 1:2000. Reagents for MHA-TP were obtained from Miles (Elkhart, IN). Primate sera were examined for IgG antibody reactivity to individual antigens of T. paflidum by immunoblot, as previously described [16] .
Infectivity ofCSF. At weeks 2,4,8, 12, 16,20, and 24, CSF was analyzed by rabbit inoculation for viable T. paflidum. CSF samples (0.5 ml) were mixed with an equal volume of normal rabbit serum and inoculated intratesticularly into separate rabbits within I h of collection. Serologic conversion ofVDRL and FTA-ABS tests within 3 months after inoculation was considered proof of infectivity of the original sample.
Immunofluorescence staining for T. paflidum. Lesion exudate was air-dried on glass slides, fixed in acetone, and stained for T. paflidum with pathogen-specific, fluorescein-conjugated monoclonal antibody H9-1 as previously described [17] .
Lymphocyte proliferation assays. Peripheral blood lymphocytes for culture were separated from whole heparinized blood on 95% Histopaque (Sigma, St. Louis) in RPMI 1640, washed three times in balanced salt solution, and resuspended at a final concentration of 1.25 X 10 6 lymphocytes/ml in complete medium containing RPMI 1640, penicillin, streptomycin, and 10% fetal bovine serum (FBS). Quadruplicate cultures containing 200 JLI of cell suspension/well (2.5 X 10 5 cells) were stimulated with 10 JLI (10 7 organisms) of sonicated T. paflidum antigen [9] . Quadruplicate cultures incubated with a mixture of monoclonal antibodies 9.3 (anti-CD28, 1.0 JLg/ml) and FN 18 (anti-CD3, 1.0 JLg/ml) and 12-o-tetradecanoylphorbol 13-acetate (0.2 ng/ml; provided by E. A. Clark, University of Washington Regional Primate Center), previously shown to produce optimal stimulation ofmacaque T lymphocytes [18] , served as positive controls, and samples without antigen were included as unstimulated negative controls. The geometric mean 24-h incorporation of[ 3H]-thymidine (0.5 JLCi in 10 JLl/well) of replicate cultures for individual animals was determined after 3, 4, and 5 days of culture, and the corresponding unstimulated background values were subtracted. The peak mean response ± SD was calculated for each group.
Lymphocyte subset analysis. A panel of mouse anti-human monoclonal antibodies that react with macaque lymphocytes was used to stain peripheral blood lymphocytes for two-color analysis using a FACScan flow cytometer (Becton Dickinson, Mountain View, CA). The antibodies were conjugated with fluorescein 5-isothiocyanate (FITC) or with R-phycoerythrin (PE) as previously described [18] . The following pairs of antibodies were used: IF5-PE (anti-CD20) and OTA4-FITC (anti-IgD), Leu-3A-PE (anti-CD4) and 3AC5-FITC (anti-CD45Ra), Leu-3A-PE (anti-CD4) and Hutch-I-FITC (anti-CD44), and G 10.1-PE (anti-CD8) and 60.3-FITC (anti-CD/8).
Isolation of SIV. Peripheral blood mononuclear cells were separated from heparinized whole blood using 95% lymphocyte separation medium (Organon Teknika-Cappel, Durham, NC) in PBS according to the manufacturer's instructions. About 2.0 X 10 6 cells were cocultured with an equal number of C8166-45 cells (obtained from R. Gallo, AIDS Research and Reference Reagent Program, National Institutes ofHealth, Bethesda, MD) and incubated at 37°C in 4 ml ofRPM I 1640-10% FBS containing 1% phytohemagglutinin and 50 units/ml interleukin-2 (Amgen, Thousand Oaks, CA); after 24-48 h, RPMI-IO% FBS was added to a final volume of 10 ml and the cultures were maintained for 4 weeks. Culture supernatant was tested for SIV at 2 and 4 weeks using a commercial HIV-1 antigen-capture test kit (Abbott Laboratories, Abbott Park, IL) according to the manufacturer's instructions.
Histology. Skin biopsy samples were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin-eosin for routine histologic examination.
Results
Clinical course. Both SlY -infected macaques had generalized lymphadenopathy, and SlY was isolated from their peripheral blood mononuclear cells at the time of T. pallidum inoculation. Immunodeficiency was documented in both animals by reduced peripheral blood absolute CD4+ lymphocyte counts and CD4+ percentages compared with controls (table I) . The SIV-uninfected control animals developed erythematous papules at the sites of T. pal/idum inoculation on day 13 after infection. These lesions reached a maximum diameter of 3 mm, persisted for only 2 days, and did not ulcerate. No further clinical manifestations were seen in the controls over 6 months of observation. In contrast, the SlY-infected animals developed erythematous papules at the sites of inoculation on day 8. These lesions reached maximum diameters of 11 mm, formed ulcerated chancres on day 16, and persisted for 38 days. T. pa/lidumwas demonstrable in lesion exudate by direct monoclonal antibody immunofluorescence testing on days 16 and 21 but not on days 28 or 38. Nine weeks after syphilis infection, 1 ofthe SlY-infected animals developed satellite lesions around the previously healed chancres and a generalized maculopapular rash. These findings persisted for 8 weeks.
Histologic examination. The skin biopsy sample of a chancre from an SlY-infected animal taken on day 14 showed the histologic characteristics ofprimary syphilis, with endothelial swelling and proliferation and moderate infiltration by lymphocytes and a few plasma cells (figure lA). Biopsy of a satellite lesion from an SIV-infected animal on day 95 was histologically consistent with secondary syphilis, with endothelial proliferation and extensive infiltrates containing lymphocytes, macrophages, and plasma cells (figure IB) .
CSF analysis. T. pal/idum was not recovered from any of the CSF samples collected. CSF cell counts in the control animals showed no significant deviation from normal values throughout the 6-month observation period. Mild mononuclear CSF pleocytosis was evident in both SlY-infected animals at baseline. The mononuclear cell count increased after syphilis infection, peaking at 12 and 18 weeks in the 2 animals (figure 2).
The CSF VORL test remained nonreactive in all 4 animals over the 6-month observation period. CSF MHA-TP reactivity was not evident at any time in the SIY-uninfected animals but was evident at low titer (1: 10-1 :20) in both SlY-infected animals from 12 to 24 weeks after syphilis infection. The CSF-to-serum albumin ratio and the MHA-TP index remained within normal limits in all 4 animals.
Immunologic responses. All 4 animals developed serologic evidence ofsyphilis. All became serum MHA-TP-reactive by 8 weeks after syphilis infection and titers plateaued at 12 weeks. The MHA-TP titers were consistently four-to eightfold higher in the SlY-infected animals than in controls (figure 3).
Serum YORL reactivity was evident in both SIY-uninfected animals by 8 weeks after infection, peaked at titers of 1:8-1: 16 at 10-12 weeks, and then declined (figure 4). In contrast, the serum YORL test was reactive in only 1 SlY-infected animal at 4 weeks (at a titer of 1:2) and was only weakly reactive or nonreactive thereafter (figure 4). This lack of reactivity was not explained by a prozone phenomenon.
Specific antibody directed against the 47-kOa antigen of
T. pal/idum was demonstrable by immunoblot by 4 weeks
after syphilis inoculation in 3 of 4 animals. All 4 developed the full profile of specific antitreponemal antibodies by 8 weeks with no detectable differences between the control and SlY-infected animals ( figure 5 ).
Lymphocyte proliferative responses to T. pal/idum antigens were evident in all 4 animals by 4-20 weeks after infection and then declined (figure 6) with no obvious quantitative difference between the control and SlY-infected animals.
Discussion
We describe the course of experimental syphilis in 2 control and 2 SlV-infected rhesus macaques over the first 6 months ofinfection. SlY exhibits -50%sequence homology with HIY-1 and 75% homology with HIY-2, and all of these viruses have similar genomic organization of both structural and functional genes, have similar protein composition, and infect cells that express the C04 receptor [8] . The immunodeficiency and illness caused by SlY in macaques is similar to that produced in humans by HIY and includes C04+ cell depletion, anemia, fever, opportunistic infections, and death after several months or years [8] .
Few data on the course of experimental syphilis in macaques are available. In 1906 Metchnikoff and Roux [19] described development of primary lesions in 4 of 10 rhesus macaques 17-24 days after intradermal inoculation with an unspecified number of T. pal/idum. In 1957 Turner and Hollander [20] observed primary lesions in all of 6 rhesus macaques by 17 days after intracutaneous inoculation with 5 X
10
6 T. pal/idum,Nichols strain; most lesions began to resolve by 28 days. Five of the 6 macaques had detectable serum nontreponemal antibody by the Eagle flocculation test. Neither study described development of secondary lesions. Despite the limitations of these studies, they demonstrate that anamnestic response to shared antigens found on previously encountered treponemes, perhaps as part ofthe oral or gastrointestinal flora, the animals in this study had no evidence of treponemal antibody by immunoblot or MHA-TP before syphilis infection. In this pilot study, syphilitic involvement of the central nervous system (CNS) was suggested in the SlY-infected animals by increasing CSF pleocytosis and demonstrable specific treponemal antibody in CSF 12-24 weeks after syphilis infection. CSF mononuclear pleocytosis and intrathecal IgG synthesis are common and nonspecific findings in individuals with HIY infection [28] and presumably reflect viral infection of the CNS. Thus, the changes we observed in CSF of the SlY-infected animals may have been due to SlY infection alone or due to superimposed CNS invasion by T. pallidum. This diagnostic dilemma is analogous to that experienced in evaluating CSF abnormalities in HIY-infected patients with syphilis. T. pal/idum can be isolated from CSF by rabbit inoculation in 30%of patients with primary or secondary syphilis, with or without HIY infection [29] . It is impossible to determine whether the failure to demonstrate T. pallidum in CSF in this study simply reflects the small sample size or differences in the frequency of CNS invasion between humans and macaques.
We are aware of only one other animal model for examining the course ofsyphilis in conjunction with retroviral infection. Tseng et al. [23] demonstrated delayed healing of primary chancres in 6 of 8 HIY-infected rabbits compared with controls, even though the rabbits had no measurable HIV-induced immunologic deficit. Our study confirms and expands on these findings, using a model in which retroviral infection caused immunodeficiency and clinical disease more analogous to HIV infection in humans. The observations provided by this model support the contention that the immunodeficiency caused by HIY results in delayed clearance of T. pallidum from sites of infection and may impair the nontreponemal humoral immune response. infection are striking findings of our study. In immunocompetent humans and experimental animals, T. pal/idum is cleared from early lesions by ingestion and killing by macrophages in the presence ofopsonic antibodies [21, 22] . Clearance oftreponemes from sites ofinfection has been shown to be delayed in experimental animals immunosuppressed with cortisone (15] and in HIY-infected rabbits despite lack of immunodeficiency [23] . Individuals with symptomatic and asymptomatic HIY infection have impaired macrophage, T, and B cell function [24] . These deficits could delay bacterial clearance from sites ofinfection by a number ofmechanisms, including inability ofantigen-specific T lymphocytes to produce macrophage-activating factors such as interferon-y, failure to develop appropriate opsonic antibody, or inability of macrophages to ingest and kill T. pal/idum. Defects in T and B cell function in retrovirus-infected hosts might explain aberrant serologic responses. A number of studies in patients with the full spectrum of HIY-induced immunosuppression document impaired antibody responses to new and to previously encountered antigens such as influenza [25] and poliovirus vaccines [26] . As expected, more impaired responses are seen in patients with more advanced HIY-related disease.
In our study, SlY-infected animals did not develop consistent reactivity in the YDRL test. While this observation may be explained by SlY-induced immunodeficiency, it is difficult to reconcile it with development of higher-titer MHA-TP responses and normal anti-T. pallidum immunoblots in these animals. YDRL antigen and T. pal/idum should be neoantigens, and synthesis of both YDRL antibody and specific treponemal antibodies is T cell-dependent [27] . While the higher-titer antitreponemal antibody could represent an 
